We are live on ! Find out more

216 hedge funds and large institutions have $4.46B invested in Genpact in 2017 Q1 according to their latest regulatory filings, with 35 funds opening new positions, 93 increasing their positions, 74 reducing their positions, and 30 closing their positions.

New
Increased
Maintained
Reduced
Closed

39% more call options, than puts

Call options by funds: $827K | Put options by funds: $595K

26% more repeat investments, than reductions

Existing positions increased: 93 | Existing positions reduced: 74

17% more first-time investments, than exits

New positions opened: 35 | Existing positions closed: 30

2.16% more ownership

Funds ownership: 88.44%90.59% (+2.2%)

3% more capital invested

Capital invested by funds: $4.32B → $4.46B (+$142M)

0% more funds holding in top 10

Funds holding in top 10: 44 (0)

1% less funds holding

Funds holding: 219216 (-3)

Holders
216
Holders Change
-3
Holders Change %
-1.37%
% of All Funds
5.35%
Holding in Top 10
4
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
0.1%
New
35
Increased
93
Reduced
74
Closed
30
Calls
$827K
Puts
$595K
Net Calls
+$232K
Net Calls Change
-$450K

G Hedge Fund Activity: Q1 2017 in Review

216 of the 4,034 institutional investors tracked by Wall St. Rank reported a position in Genpact (G) for Q1 2017, worth a combined $4.46B — up 3.3% from $4.32B a quarter earlier.

Buyers outnumbered sellers: 35 funds opened new G positions and 30 closed out — a net gain of 5 holders — while 93 added to existing stakes and 74 trimmed.

The largest buyer was BlackRock, adding an estimated $180M. The largest seller was Eminence Capital, exiting entirely with an estimated $126M sold.

  • 216 institutional investors held Genpact (G) as of Q1 2017, down from 219 in Q4 2016.
  • Funds reported $4.46B of Genpact stock for Q1 2017, up 3.3% quarter-over-quarter.
  • 35 funds opened new Genpact positions in Q1 2017 and 30 closed out, a net change of +5 holders.
  • The largest Genpact buyer in Q1 2017 was BlackRock, an estimated $180M added.
  • The largest Genpact seller in Q1 2017 was Eminence Capital, an estimated $126M sold.

Based on aggregated 13F filings for Q1 2017.